ArticleInternal medicine (Tokyo, Japan)2026
The Impact of Rifaximin on Hepatic Encephalopathy during Lenvatinib Therapy in Patients with Hepatocellular Carcinoma and Splenorenal Shunt.
Shigeo Shimose et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.